PH25389A - Novel thiazole derivatives active on the cholinergic system, process for obtention, pharmaceutical compositions - Google Patents

Novel thiazole derivatives active on the cholinergic system, process for obtention, pharmaceutical compositions

Info

Publication number
PH25389A
PH25389A PH36616A PH36616A PH25389A PH 25389 A PH25389 A PH 25389A PH 36616 A PH36616 A PH 36616A PH 36616 A PH36616 A PH 36616A PH 25389 A PH25389 A PH 25389A
Authority
PH
Philippines
Prior art keywords
obtention
pharmaceutical compositions
thiazole derivatives
cholinergic system
derivatives active
Prior art date
Application number
PH36616A
Other languages
English (en)
Inventor
Kathleen Biziere
Dominique Olliero
Paul Worms
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PH25389A publication Critical patent/PH25389A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
PH36616A 1987-03-12 1988-03-09 Novel thiazole derivatives active on the cholinergic system, process for obtention, pharmaceutical compositions PH25389A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8703398A FR2612187B1 (fr) 1987-03-12 1987-03-12 Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
PH25389A true PH25389A (en) 1991-06-03

Family

ID=9348897

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36616A PH25389A (en) 1987-03-12 1988-03-09 Novel thiazole derivatives active on the cholinergic system, process for obtention, pharmaceutical compositions

Country Status (27)

Country Link
EP (1) EP0283390B1 (de)
JP (1) JPS63243080A (de)
KR (1) KR880011135A (de)
AR (1) AR243515A1 (de)
AT (1) ATE86249T1 (de)
AU (1) AU612350B2 (de)
DD (1) DD274028A5 (de)
DE (1) DE3878708T2 (de)
DK (1) DK170162B1 (de)
ES (1) ES2053778T3 (de)
FI (1) FI881152A7 (de)
FR (1) FR2612187B1 (de)
HU (1) HU198916B (de)
IE (1) IE60173B1 (de)
IL (1) IL85704A (de)
MA (1) MA21207A1 (de)
MY (1) MY103233A (de)
NO (1) NO170081C (de)
NZ (1) NZ223845A (de)
OA (1) OA08871A (de)
PH (1) PH25389A (de)
PL (1) PL151889B1 (de)
PT (1) PT86952B (de)
SU (1) SU1604157A3 (de)
TN (1) TNSN88020A1 (de)
YU (1) YU49688A (de)
ZA (1) ZA881764B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440474A (en) * 1987-08-04 1989-02-10 Hisamitsu Pharmaceutical Co Novel 2-substituted aminothiazole derivative
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
WO1991018882A1 (fr) * 1990-05-29 1991-12-12 Nippon Soda Co., Ltd. Derive d'amidine heterocyclique n-substitue
FR2677021B1 (fr) * 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
WO1992021666A1 (fr) * 1991-05-31 1992-12-10 Laboratoires Upsa Derives de thiazole antagonistes de recepteurs a l'angiotensine ii
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
AU4982293A (en) * 1993-03-02 1994-09-26 Fujisawa Pharmaceutical Co., Ltd. Novel heterocyclic compound
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
GB9705428D0 (en) * 1997-03-15 1997-04-30 Knoll Ag Therapeutic agents
CA2332325A1 (en) * 1998-06-18 1999-12-23 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
PT1183245E (pt) 1999-04-22 2007-07-12 Lundbeck & Co As H Antagonistas selectivos de npy (y5)
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
US7485655B2 (en) * 2002-01-16 2009-02-03 University Of Virginia Patent Foundation 2-Aminothiazole allosteric enhancers of A1 adenosine receptors
DE10251513A1 (de) * 2002-11-04 2004-05-19 Basf Ag Übergangsmetallkatalysatoren für (Co)Polymerisation von olefinischen Monomeren
JP2007261945A (ja) * 2004-04-07 2007-10-11 Taisho Pharmaceut Co Ltd チアゾール誘導体
JP5388574B2 (ja) * 2005-05-31 2014-01-15 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルのモジュレーターとして有用なヘテロ環式類
KR20110137941A (ko) * 2010-06-18 2011-12-26 (주) 에빅스젠 신규한 티오우레아 또는 우레아 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 ａｉｄｓ 예방 또는 치료용 약학 조성물
RU2456284C1 (ru) * 2011-04-12 2012-07-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" 2-аминопропилморфолино-5-арил-6н-1,3,4-тиадиазины, дигидробромиды и 2-аминопропилморфолино-4-арилтиазолы, гидробромиды, обладающие антиагрегантным действием
ES2820585T3 (es) * 2014-11-10 2021-04-21 Evrys Bio Llc Composiciones y métodos anti-HCMV
CN115160207B (zh) * 2022-04-21 2023-09-26 烟台大学 苯甲酰硫脲类化合物及其制备方法和赤潮藻杀藻剂的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975182A (en) * 1959-11-16 1961-03-14 Paul A J Janssen 1-(aroylalkyl)-4-(heterocyclyl) piperazines
FR2092714B1 (de) * 1970-06-11 1974-03-22 Melle Bezons
CH583232A5 (de) * 1973-02-02 1976-12-31 Wander Ag Dr A
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
NL8601494A (nl) * 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
NO170081B (no) 1992-06-01
MY103233A (en) 1993-05-29
FI881152A0 (fi) 1988-03-11
DE3878708D1 (de) 1993-04-08
AU1266288A (en) 1988-09-15
PT86952B (pt) 1992-05-29
ZA881764B (en) 1988-08-31
PL271132A1 (en) 1988-11-24
ATE86249T1 (de) 1993-03-15
NO170081C (no) 1992-09-09
EP0283390A3 (en) 1988-09-28
IE60173B1 (en) 1994-06-15
JPS63243080A (ja) 1988-10-07
PT86952A (pt) 1988-04-01
KR880011135A (ko) 1988-10-26
DD274028A5 (de) 1989-12-06
DK128688A (da) 1988-09-13
IE880721L (en) 1988-09-12
OA08871A (fr) 1989-10-31
TNSN88020A1 (fr) 1990-07-10
PL151889B1 (en) 1990-10-31
DE3878708T2 (de) 1993-09-02
DK128688D0 (da) 1988-03-09
IL85704A (en) 1992-11-15
FR2612187A1 (fr) 1988-09-16
HU198916B (en) 1989-12-28
FI881152A7 (fi) 1988-09-13
FR2612187B1 (fr) 1989-07-21
NZ223845A (en) 1990-11-27
ES2053778T3 (es) 1994-08-01
IL85704A0 (en) 1988-08-31
AU612350B2 (en) 1991-07-11
EP0283390B1 (de) 1993-03-03
MA21207A1 (fr) 1988-10-01
YU49688A (en) 1989-10-31
EP0283390A2 (de) 1988-09-21
NO881093D0 (no) 1988-03-11
HUT47261A (en) 1989-02-28
AR243515A1 (es) 1993-08-31
SU1604157A3 (ru) 1990-10-30
DK170162B1 (da) 1995-06-06
NO881093L (no) 1988-09-13

Similar Documents

Publication Publication Date Title
PH25389A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention, pharmaceutical compositions
AR243491A1 (es) Procedimiento para preparar derivados de catecol farmacologicamente activos.
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ240378A (en) Substituted thiazolidinedione derivatives; pharmaceutical compositions,
IL87731A0 (en) Cephem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH21118A (en) Heterocyclic derivatives, a process for their preparation the pharmaceutical composition containing them
NZ226337A (en) Substituted alkadiene derivatives, processes for their preparation, and pharmaceutical compositions
IL87563A (en) Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ZA897541B (en) Benzoxazolinone derivatives,process for the preparation thereof and pharmaceutical compositions containing them
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU2346088A (en) Pharmaceutical composition for piperidinoalkanol derivatives
ZA82820B (en) Thiazolidine derivatives having pharmacological activity, process for the preparation thereof and pharmaceutical compositions comprising said derivatives
AU1563388A (en) New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL66277A (en) 3,7-dialkyl-3,7-diazabicyclo(3.3.1)nonan-9-ol derivatives,a process for the preparation thereof and pharmaceutical compositions containing them
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
ZA886160B (en) Cephalosporin compounds,process for their preparation and their pharmaceutical compositions
IL86269A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB2190678B (en) 3-(hydroxymethyl)-isoquinoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
HUT43490A (en) Process for producing pharmaceutical compositions containing 2-alkoxy-(1-azabicyclo-(-2,2,2-)-okt-3-yl-benzamide)-n-oxide derivatives
EP0300036A4 (de) Auf vasopressin basierte arzneimittelzubereitungen.
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU1487988A (en) Package, for instance for tablets for pharmaceutical use
EP0172919A4 (de) Cephalosporinabkömmlinge, deren herstellungsverfahren und deren verwendung als arzneimittel.